The antiproteinuric effect of the blockage of the renin-angiotensin-aldosterone system (RAAS) in obese patients. Which treatment option is the most effective?
Efecto antiproteinúrico del bloqueo del sistema renina-angiotensina-aldosterona (SRAA) en los pacientes obesos. ¿Cuál es la opción terapéutica más eficaz?
Leído
11332
Vecesse ha leído el artículo
2983
Total PDF
8349
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 11 | 78 | 14 | 92 |
| 2025 10 | 123 | 48 | 171 |
| 2025 9 | 99 | 32 | 131 |
| 2025 8 | 68 | 35 | 103 |
| 2025 7 | 90 | 30 | 120 |
| 2025 6 | 64 | 94 | 158 |
| 2025 5 | 93 | 32 | 125 |
| 2025 4 | 76 | 35 | 111 |
| 2025 3 | 106 | 63 | 169 |
| 2025 2 | 90 | 48 | 138 |
| 2025 1 | 83 | 31 | 114 |
| 2024 12 | 105 | 33 | 138 |
| 2024 11 | 78 | 54 | 132 |
| 2024 10 | 72 | 58 | 130 |
| 2024 9 | 64 | 33 | 97 |
| 2024 8 | 75 | 53 | 128 |
| 2024 7 | 55 | 29 | 84 |
| 2024 6 | 75 | 33 | 108 |
| 2024 5 | 80 | 40 | 120 |
| 2024 4 | 70 | 39 | 109 |
| 2024 3 | 69 | 35 | 104 |
| 2024 2 | 65 | 55 | 120 |
| 2024 1 | 50 | 25 | 75 |
| 2023 12 | 48 | 26 | 74 |
| 2023 11 | 39 | 75 | 114 |
| 2023 10 | 67 | 32 | 99 |
| 2023 9 | 57 | 34 | 91 |
| 2023 8 | 36 | 38 | 74 |
| 2023 7 | 47 | 48 | 95 |
| 2023 6 | 58 | 38 | 96 |
| 2023 5 | 67 | 64 | 131 |
| 2023 4 | 45 | 65 | 110 |
| 2023 3 | 66 | 26 | 92 |
| 2023 2 | 61 | 20 | 81 |
| 2022 1 | 59 | 32 | 91 |
| 2022 12 | 52 | 20 | 72 |
| 2022 11 | 57 | 34 | 91 |
| 2022 10 | 48 | 43 | 91 |
| 2022 9 | 52 | 36 | 88 |
| 2022 8 | 53 | 49 | 102 |
| 2022 7 | 39 | 54 | 93 |
| 2022 6 | 49 | 33 | 82 |
| 2022 5 | 48 | 35 | 83 |
| 2022 4 | 36 | 44 | 80 |
| 2022 3 | 53 | 48 | 101 |
| 2022 2 | 44 | 34 | 78 |
| 2021 1 | 40 | 33 | 73 |
| 2021 12 | 29 | 39 | 68 |
| 2021 11 | 38 | 37 | 75 |
| 2021 10 | 57 | 34 | 91 |
| 2021 9 | 29 | 30 | 59 |
| 2021 8 | 34 | 34 | 68 |
| 2021 7 | 52 | 30 | 82 |
| 2021 6 | 27 | 23 | 50 |
| 2021 5 | 36 | 24 | 60 |
| 2021 4 | 125 | 41 | 166 |
| 2021 3 | 52 | 19 | 71 |
| 2021 2 | 56 | 17 | 73 |
| 2020 1 | 56 | 30 | 86 |
| 2020 12 | 31 | 8 | 39 |
| 2020 11 | 43 | 16 | 59 |
| 2020 10 | 25 | 10 | 35 |
| 2020 9 | 34 | 2 | 36 |
| 2020 8 | 50 | 8 | 58 |
| 2020 7 | 30 | 8 | 38 |
| 2020 6 | 40 | 9 | 49 |
| 2020 5 | 60 | 13 | 73 |
| 2020 4 | 39 | 17 | 56 |
| 2020 3 | 43 | 7 | 50 |
| 2020 2 | 70 | 21 | 91 |
| 2020 1 | 61 | 25 | 86 |
| 2019 12 | 99 | 25 | 124 |
| 2019 11 | 116 | 20 | 136 |
| 2019 10 | 87 | 20 | 107 |
| 2019 9 | 85 | 15 | 100 |
| 2019 8 | 52 | 23 | 75 |
| 2019 7 | 64 | 23 | 87 |
| 2019 6 | 58 | 17 | 75 |
| 2019 5 | 52 | 10 | 62 |
| 2019 4 | 116 | 38 | 154 |
| 2019 3 | 51 | 19 | 70 |
| 2019 2 | 35 | 20 | 55 |
| 2019 1 | 43 | 16 | 59 |
| 2018 12 | 83 | 23 | 106 |
| 2018 11 | 89 | 16 | 105 |
| 2018 10 | 106 | 16 | 122 |
| 2018 9 | 91 | 17 | 108 |
| 2018 8 | 43 | 10 | 53 |
| 2018 7 | 53 | 15 | 68 |
| 2018 6 | 49 | 17 | 66 |
| 2018 5 | 51 | 13 | 64 |
| 2018 4 | 40 | 7 | 47 |
| 2018 3 | 51 | 7 | 58 |
| 2018 2 | 43 | 5 | 48 |
| 2018 1 | 42 | 6 | 48 |
| 2017 12 | 52 | 13 | 65 |
| 2017 11 | 38 | 3 | 41 |
| 2017 10 | 36 | 10 | 46 |
| 2017 9 | 45 | 8 | 53 |
| 2017 8 | 55 | 13 | 68 |
| 2017 7 | 47 | 4 | 51 |
| 2017 6 | 52 | 9 | 61 |
| 2017 5 | 47 | 9 | 56 |
| 2017 4 | 35 | 15 | 50 |
| 2017 3 | 35 | 9 | 44 |
| 2017 2 | 39 | 11 | 50 |
| 2016 1 | 36 | 14 | 50 |
| 2016 12 | 71 | 6 | 77 |
| 2016 11 | 63 | 14 | 77 |
| 2016 10 | 97 | 4 | 101 |
| 2016 9 | 120 | 11 | 131 |
| 2016 8 | 141 | 4 | 145 |
| 2016 7 | 166 | 16 | 182 |
| 2016 6 | 155 | 0 | 155 |
| 2016 5 | 149 | 0 | 149 |
| 2016 4 | 118 | 0 | 118 |
| 2016 3 | 108 | 0 | 108 |
| 2016 2 | 98 | 0 | 98 |
| 2015 1 | 140 | 0 | 140 |
| 2015 12 | 136 | 0 | 136 |
| 2015 11 | 92 | 0 | 92 |
| 2015 10 | 81 | 0 | 81 |
| 2015 9 | 78 | 0 | 78 |
| 2015 8 | 75 | 0 | 75 |
| 2015 7 | 69 | 0 | 69 |
| 2015 6 | 46 | 0 | 46 |
| 2015 5 | 58 | 0 | 58 |
| 2015 4 | 6 | 0 | 6 |
Mostrar todo
